| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |